Fiala, O
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study -
Ondřej Fiala,
Sebastiano Buti,
Hideki Takeshita,
Yohei Okada,
Francesco Massari,
Georgia Anguera Palacios,
Michele Dionese,
Sarah Scagliarini,
Thomas Büttner,
Giuseppe Fornarini,
Zin W Myint,
Luca Galli,
Vinicius Carrera Souza,
Renate Pichler,
Ugo De Giorgi,
María Natalia Gandur Quiroga,
Danielle Gilbert,
Lazar Popovic,
Enrique Grande,
Giulia Mammone,
Rossana Berardi,
Simon J. Crabb,
Javier Molina-Cerrillo,
Marcelo Freitas,
Murilo Luz,
Roberto Iacovelli,
Fabio Calabrò,
Deniz Tural,
Francesco Atzori,
Zsófia Küronya,
Rita Chiari,
Saul Campos,
Orazio Caffo,
André P Fay,
Jakub Kucharz,
Paolo Andrea Zucali,
José Augusto Rinck,
Annalisa Zeppellini,
Diogo Assed Bastos,
Gaetano Aurilio,
Augusto Mota,
Karine Trindade,
Cinzia Ortega,
Juan Pablo Sade,
Mimma Rizzo,
Nuno Vau,
Patrizia Giannatempo,
Allan Barillas,
Fernando Sabino Marques Monteiro,
Breno Dauster,
Carlo Cattrini,
Lucas Nogueira,
Roni de Carvalho Fernandes,
Emmanuel Seront,
Luís Garcia Aceituno,
Francesco Grillone,
Hernan Javier Cutuli,
Mauricio Fernandez,
Maria Bassanelli,
Giandomenico Roviello,
Halima Abahssain,
Giuseppe Procopio,
Michele Milella,
Jindrich Kopecky,
Angelo Martignetti,
Carlo Messina,
Manuel Caitano,
Eva Inman,
Ravindran Kanesvaran,
Daniel Herchenhorn,
Daniele Santini,
Ray Manneh,
Renato Bisonni,
Roubini Zakopoulou,
Alessandra Mosca,
Franco Morelli,
Fernando Maluf,
Andrey Soares,
Fernando Nunes,
Alvaro Pinto,
Anca Zgura,
Lorena Incorvaia,
Jawaher Ansari,
Ignacio Ortego Zabalza,
Johannes Landmesser,
Alessandro Rizzo,
Veronica Mollica,
Giulia Sorgentoni,
Nicola Battelli,
Camillo Porta,
Joaquim Bellmunt and
Matteo Santoni
Type: Article
| 2023
Lolli, C
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib. -
Cristian Lolli,
Umberto Basso,
Lisa Derosa,
Emanuela Scarpi,
Teodoro Sava,
Matteo Santoni,
Simon J. Crabb,
Francesco Massari,
Michele Aieta,
Vincenza Conteduca,
Marco Maruzzo,
Francesca La Russa,
Matthew Wheater,
Rossana Berardi,
Luca Galli and
Ugo De Giorgi
Type: Article
| 2016
Massari, F
Rossi, L
High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer -
Lorena Rossi,
Matteo Santoni,
Simon J. Crabb,
Emanuela Scarpi,
Luciano Burattini,
Caroline Chau,
Emanuela Bianchi,
Agnese Savini,
Salvatore L. Burgio,
Alessandro Conti,
Vincenza Conteduca,
Stefano Cascinu and
Ugo De Giorgi
Type: Article
| 2014
| Item not available on this server.
Santoni, M
Type: Article
| 2014
| Item not available on this server.
Real-world data on cabozantinib in previously treated patients with metastatic renal cell carcinoma: Focus on sequences and prognostic factors -
Matteo Santoni,
Daniel Y. Heng,
Sergio Bracarda,
Giuseppe Procopio,
Michele Milella,
Camillo Porta,
Marc R. Matrana,
Giacomo Cartenì,
Simon J. Crabb,
Ugo De Giorgi,
Umberto Basso,
Cristina Masini,
Fabio Calabrò,
Maria Giuseppa Vitale,
Daniele Santini,
Francesco Massari,
Luca Galli,
Giuseppe Fornarini,
Riccardo Ricotta,
Sebastiano Buti,
Paolo Zucali,
Orazio Caffo,
Franco Morelli,
Francesco Carrozza,
Angelo Martignetti,
Alain Gelibter,
Roberto Iacovelli,
Alessandra Mosca,
Francesco Atzori,
Nuno Vau,
Lorena Incorvaia,
Cinzia Ortega,
Marina Scarpelli,
Antonio Lopez-Beltran,
Liang Cheng,
Vittorio Paolucci,
Jeffrey Graham,
Erin Pierce,
Sarah Scagliarini,
Pierangela Sepe,
Elena Verzoni,
Sara Merler,
Mimma Rizzo,
Giulia Sorgentoni,
Alessandro Conti,
Francesco Piva,
Alessia Cimadamore,
Rodolfo Montironi and
Nicola Battelli
Type: Article
| 2019
Body mass index in patients treated with cabozantinib for advanced renal cell carcinoma: A new prognostic factor? -
Matteo Santoni,
Francesco Massari,
Sergio Bracarda,
Giuseppe Procopio,
Michele Milella,
Ugo De Giorgi,
Umberto Basso,
Gaetano Aurilio,
Lorena Incorvaia,
Angelo Martignetti,
Mimma Rizzo,
Giacomo Cartenì,
Enrique Grande,
Marc R Matrana,
Simon J Crabb,
Nuno Vau,
Giulia Sorgentoni,
Alessia Cimadamore,
Rodolfo Montironi and
Nicola Battelli
Type: Article
| 2021
Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study -
Matteo Santoni,
Zin W Myint,
Thomas Büttner,
Hideki Takeshita,
Yohei Okada,
Elaine T Lam,
Danielle Gilbert,
Zsófia Küronya,
Deniz Tural,
Renate Pichler,
Enrique Grande,
Simon J Crabb,
Robert Kemp,
Francesco Massari,
Sarah Scagliarini,
Roberto Iacovelli,
Nuno Vau,
Umberto Basso,
Marco Maruzzo,
Javier Molina-Cerrillo,
Luca Galli,
Aristotelis Bamias,
Ugo De Giorgi,
Paolo Andrea Zucali,
Mimma Rizzo,
Emmanuel Seront,
Lazar Popovic,
Orazio Caffo,
Sebastiano Buti,
Ravindran Kanesvaran,
Jindrich Kopecky,
Jakub Kucharz,
Annalisa Zeppellini,
Ondřej Fiala,
Johannes Landmesser,
Jawaher Ansari,
Patrizia Giannatempo,
Alessandro Rizzo,
Ignacio Ortego Zabalza,
Fernando Sabino M Monteiro,
Nicola Battelli,
Fabio Calabrò and
Camillo Porta
Type: Article
| 2023
This list was generated on Thu Aug 28 12:18:42 2025 BST.